190 related articles for article (PubMed ID: 23485397)
21. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
22. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.
Sung KS; Go YY; Ahn JH; Kim YH; Kim Y; Choi CY
FEBS Lett; 2005 Jun; 579(14):3001-8. PubMed ID: 15896780
[TBL] [Abstract][Full Text] [Related]
23. Heat shock modulates the subcellular localization, stability, and activity of HIPK2.
Upadhyay M; Bhadauriya P; Ganesh S
Biochem Biophys Res Commun; 2016 Apr; 472(4):580-4. PubMed ID: 26972256
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
Ohtsu N; Nobuhisa I; Mochita M; Taga T
Exp Cell Res; 2007 Jan; 313(1):88-97. PubMed ID: 17064687
[TBL] [Abstract][Full Text] [Related]
25. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
[TBL] [Abstract][Full Text] [Related]
26. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
[TBL] [Abstract][Full Text] [Related]
27. Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility.
Pierantoni GM; Esposito F; Tornincasa M; Rinaldo C; Viglietto G; Soddu S; Fusco A
J Biol Chem; 2011 Aug; 286(33):29005-29013. PubMed ID: 21715331
[TBL] [Abstract][Full Text] [Related]
28. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells.
D'Orazi G; Sciulli MG; Di Stefano V; Riccioni S; Frattini M; Falcioni R; Bertario L; Sacchi A; Patrignani P
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):735-41. PubMed ID: 16467083
[TBL] [Abstract][Full Text] [Related]
29. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
[TBL] [Abstract][Full Text] [Related]
30. Unveiling the novel dual specificity protein kinases in Bacillus anthracis: identification of the first prokaryotic dual specificity tyrosine phosphorylation-regulated kinase (DYRK)-like kinase.
Arora G; Sajid A; Arulanandh MD; Singhal A; Mattoo AR; Pomerantsev AP; Leppla SH; Maiti S; Singh Y
J Biol Chem; 2012 Aug; 287(32):26749-63. PubMed ID: 22711536
[TBL] [Abstract][Full Text] [Related]
31. US11 of herpes simplex virus type 1 interacts with HIPK2 and antagonizes HIPK2-induced cell growth arrest.
Giraud S; Diaz-Latoud C; Hacot S; Textoris J; Bourette RP; Diaz JJ
J Virol; 2004 Mar; 78(6):2984-93. PubMed ID: 14990717
[TBL] [Abstract][Full Text] [Related]
32. p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function.
Choi JR; Lee SY; Shin KS; Choi CY; Kang SJ
Sci Rep; 2017 Nov; 7(1):16136. PubMed ID: 29170424
[TBL] [Abstract][Full Text] [Related]
33. Programmed cell death 4 protein (Pdcd4) and homeodomain-interacting protein kinase 2 (Hipk2) antagonistically control translation of Hipk2 mRNA.
Ohnheiser J; Ferlemann E; Haas A; Müller JP; Werwein E; Fehler O; Biyanee A; Klempnauer KH
Biochim Biophys Acta; 2015 Jul; 1853(7):1564-73. PubMed ID: 25820028
[TBL] [Abstract][Full Text] [Related]
34. The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2.
Glenewinkel F; Cohen MJ; King CR; Kaspar S; Bamberg-Lemper S; Mymryk JS; Becker W
Sci Rep; 2016 Jun; 6():28241. PubMed ID: 27307198
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
36. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
[TBL] [Abstract][Full Text] [Related]
37. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
38. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.
Pierantoni GM; Rinaldo C; Mottolese M; Di Benedetto A; Esposito F; Soddu S; Fusco A
J Clin Invest; 2007 Mar; 117(3):693-702. PubMed ID: 17290307
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
40. Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.
Soundararajan M; Roos AK; Savitsky P; Filippakopoulos P; Kettenbach AN; Olsen JV; Gerber SA; Eswaran J; Knapp S; Elkins JM
Structure; 2013 Jun; 21(6):986-96. PubMed ID: 23665168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
